HER3-DXd
U31402-277
Phase 2 small_molecule active
Quick answer
HER3-DXd for Advanced Solid Tumor is a Phase 2 program (small_molecule) at Daiichi Sankyo with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo
- Indication
- Advanced Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active